NEOGENOMICS INC 8-K

What Happened

• On June 17, 2026, NeoGenomics, Inc. announced the pricing of an offering of convertible senior notes due 2032. The company issued a press release about the pricing and filed that release as Exhibit 99.1 to its Form 8‑K. The offering is being made to persons reasonably believed to be qualified institutional buyers under Rule 144A.

Key Details

• Date of filing: June 17, 2026.
• Security: Convertible senior notes due 2032.
• Target purchasers: Qualified institutional buyers pursuant to Rule 144A.
• Filing: Press release attached as Exhibit 99.1; the 8‑K states it is not an offer to sell or a solicitation in jurisdictions where unlawful.

Why It Matters

• This is a debt financing event that could affect NeoGenomics’ capital structure and future share count if the notes are converted into equity. Investors should review the press release and watch for follow‑on SEC filings that disclose the offering size, interest rate, conversion terms, and intended use of proceeds to assess potential dilution, changes to leverage, and impacts on credit profile.